Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-02 | Dr. Hillan has served as Head of Therapeutics of 23andMe, Inc., a consumer genetics and research company. He has held leadership positions in clinical development and product development strategy. |
| 2022-04-01 | Dr. Hillan has served as Head of Therapeutics of 23andMe Holding Co., a public consumer genetics and research company. He has extensive experience and knowledge in the development of therapeutics and in the biotechnology industry. |
Data sourced from SEC filings. Last updated: 2025-10-12